Keyphrases
Inflammatory Bowel Disease
100%
Crohn's Disease
91%
Indoleamine 2,3-dioxygenase 1 (IDO1)
43%
Colorectal Cancer
38%
Ulcerative Colitis
31%
COVID-19
29%
Small Intestine
29%
Gastrointestinal Diseases
25%
Intestinal Epithelial Cells
24%
Enterotoxigenic Escherichia Coli
24%
Vedolizumab
23%
Cancer Therapy
21%
Inflammation
20%
Non-alcoholic Fatty Liver Disease (NAFLD)
19%
Colitis
18%
Hyaluronic Acid
17%
Irritable Bowel Syndrome
16%
Chronic Inflammatory Diseases
16%
Tofacitinib
16%
Toll-like Receptor 4 (TLR4)
15%
Radiation Damage
15%
Lgr5+
14%
Methionine Oxidation
14%
Intestinal Epithelium
14%
Innate Immune Response
14%
Vaccination
14%
Cluster of Differentiation 44 (CD44)
13%
Dextran Sulfate Sodium
12%
Kynurenine Pathway
12%
Tryptophan
11%
Apoptosis
11%
Tryptophan Metabolism
11%
Diarrhea
11%
Crohn's Disease Activity
11%
Intestinal Growth
11%
Mucositis
11%
Gastrointestinal Tract
11%
United States
11%
Magnetic Resonance Enterography
11%
Clinical Trials
11%
Cancer Cell Proliferation
10%
Crypt Fission
10%
Colon Cancer
10%
Sleep Disturbance
10%
Cyclooxygenase-2
10%
Radioprotection
9%
Training Challenges
9%
Small Molecules
9%
Stem Cell Proliferation
9%
Leucine-rich Repeat
9%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
55%
Crohn's Disease
38%
Diseases
38%
Malignant Neoplasm
35%
Ulcerative Colitis
27%
Indoleamine 2,3 Dioxygenase
26%
Colitis
21%
Colorectal Carcinoma
19%
Infection
18%
Carcinogenesis
18%
Vedolizumab
18%
Biological Marker
17%
SARS Coronavirus
17%
Radiation Injury
17%
Tofacitinib
16%
Clinical Trial
15%
Inflammatory Disease
15%
Biological Product
14%
Kynurenine
14%
Colon Carcinoma
14%
Inflammation
14%
Messenger RNA
12%
Tryptophan
12%
Mucosa Inflammation
11%
Gastrointestinal Symptom
10%
Sleep Disorder
10%
Toll Like Receptor 4
10%
Cohort Study
10%
Immunogenicity
9%
Lactobacillus rhamnosus
9%
Hyaluronic Acid
9%
Adverse Event
9%
Microflora
8%
Intestine Flora
8%
Tumor Necrosis Factor Inhibitor
8%
Remission
8%
Neoplasm
8%
Enteritis
8%
Janus Kinase Inhibitor
7%
Dextran Sulfate
7%
Cyclooxygenase 2
7%
Pyroptosis
7%
Chemotherapy
6%
Clostridium Difficile Infection
6%
Catenin
6%
Microbiome
6%
Lactobacillus
6%
Irritable Colon
6%
Disease Course
6%
Azoxymethane
6%
Medicine and Dentistry
Inflammatory Bowel Disease
76%
Crohn's Disease
36%
Probiotics
27%
Diseases
26%
Ulcerative Colitis
21%
Colorectal Carcinoma
18%
Stem Cell
17%
Cancer Therapy
15%
Toll Like Receptor 4
15%
Gastrointestinal Distress
14%
Nonalcoholic Fatty Liver
14%
Indoleamine 2,3 Dioxygenase
14%
Restylane
14%
Vedolizumab
13%
Cell Proliferation
12%
Radiation Therapy
12%
Epithelial Cell
11%
Colitis
11%
Disease Course
11%
Magnetic Resonance Enterography
10%
Diarrhea
10%
Irritable Bowel Syndrome
10%
Rectum Cancer
9%
Bariatric Surgery
9%
Enterotoxigenic Escherichia Coli
9%
Mucositis
9%
Radiation Injury
9%
Clinical Trial
9%
Disease Activity
9%
Patient with Inflammatory Bowel Disease
9%
Gut
8%
Programmed Cell Death
8%
Biological Marker
7%
COVID-19
7%
Infection
7%
Enteritis
7%
Mucus
7%
Myofibroblast
7%
TNF Inhibitor
7%
Dextran Sulfate
6%
Immunotherapy
6%
Systematic Review
6%
Prevalence
6%
Patient with Crohn's Disease
6%
Intestinal Epithelium
6%
Cyclooxygenase 2
6%
Organismal Interaction
6%
Colon Carcinoma
6%
Receptor
6%
Hazard Ratio
5%